Gapping up
In reaction to earnings/guidance:
- SONO +19.7% (says it reached an inflection point in SepQ; also announces $50 mln stock repurchase plan), LB +16.9% (also comps +28%), FUTU +10.2%, PLCE +7.7%, BERY +6.6%, JACK +5.9% (also reports strong comps at +12.2%), BILI +5.5%, ATKR +4.7%, NUAN +3.9% (also to sell HIM Transcription and EHR Go-Live Services businesses), OCSL +3.9%, BRC +3.9%, KLIC +2.6%, PAGS +2.4%, NTES +2.3%, UGI +1.6%, .
Other news:
- APVO +32.5% (receives $50/share acquisition proposal from shareholder Tang Capital)
- CORT +21.1% (Patent Trial and Appeal Board upheld the validity of all claims of CORT's '214 patent)
- LNTH +11.3% (FDA approves sNDA for DEFINITY Room Temperature)
- AQST +9.9% (completes FDA meeting on Libervant; believes no additional clinical studies needed for NDA resubmission)
- RDHL +8.9% (announces unanimous DSMB recommendation to continue phase 2/3 COVID-19 study with opaganib; Emergency use authorization applications planned as early as Q1/2021)
- PLYA +7.9% (prices secondary offering of 13,575,739 of its ordinary shares by certain selling shareholders at $4.10 per share)
- RIG +4.1% (announces that Petrobras extends two rig contracts)
- PLTR +3% (receives prototype contract from the US Army)
- ORTX +3% (FDA clearance of IND application for OTL-200 for metachromatic leukodystrophy)
- SBGI +2.6% (Sinclair Broadcast and Bally's for strategic partnership for long-term sports betting and iGaming)
- VERI +2.5% (received three new patents for its battery control technology)
- BNTX +2.3% (QGEN and BNTX to collaborate on diagnostic development for HPV squamous cell carcinoma)